Benign Prostatic Hyperplasia Treatment Market Report

China Benign Prostatic Hyperplasia Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：233
  • REPORT CODE：GMM1759045
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Benign Prostatic Hyperplasia Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck

    • LISA Laser

    • Olympus

    • Allergan plc

    • Astellas Pharma

    • Teleflex Incorporated

    • Boston Scientific Corporation

    • Endo International

    • Abbott

    • Pfizer

    • Sanofi

    • Boehringer Ingelheim GmbH

    • GlaxoSmithKline

    By Type:

    • Laser Therapy

    • Drug Class

    • Minimally Invasive Surgeries

    • Others

    By Application:

    • Ambulatory Surgical Centers

    • Others

    • Hospitals

    • Specialty Clinics

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Benign Prostatic Hyperplasia Treatment Market Overview 2018-2029

    • 1.1 China Benign Prostatic Hyperplasia Treatment Industry Development Overview

    • 1.2 China Benign Prostatic Hyperplasia Treatment Industry Development History

    • 1.3 China Benign Prostatic Hyperplasia Treatment Industry Market Size (2018-2029)

    • 1.4 China Benign Prostatic Hyperplasia Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Benign Prostatic Hyperplasia Treatment Production Volume, Production Value and Growth Rate of Laser Therapy (2018-2029)

      • 1.4.2 China Benign Prostatic Hyperplasia Treatment Production Volume, Production Value and Growth Rate of Drug Class (2018-2029)

      • 1.4.3 China Benign Prostatic Hyperplasia Treatment Production Volume, Production Value and Growth Rate of Minimally Invasive Surgeries (2018-2029)

      • 1.4.4 China Benign Prostatic Hyperplasia Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Benign Prostatic Hyperplasia Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Benign Prostatic Hyperplasia Treatment Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

      • 1.5.2 China Benign Prostatic Hyperplasia Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Benign Prostatic Hyperplasia Treatment Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.4 China Benign Prostatic Hyperplasia Treatment Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)

    • 1.6 China Benign Prostatic Hyperplasia Treatment Market Analysis by Region

      • 1.6.1 North China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Benign Prostatic Hyperplasia Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Benign Prostatic Hyperplasia Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Benign Prostatic Hyperplasia Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Benign Prostatic Hyperplasia Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Benign Prostatic Hyperplasia Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Benign Prostatic Hyperplasia Treatment Industry Development

    Chapter 3 Benign Prostatic Hyperplasia TreatmentIndustry Chain Analysis

    • 3.1 Benign Prostatic Hyperplasia Treatment Industry Chain

    • 3.2 Benign Prostatic Hyperplasia Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Benign Prostatic Hyperplasia Treatment Market

    • 3.3 Benign Prostatic Hyperplasia Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Benign Prostatic Hyperplasia Treatment Market

    Chapter 4 China Benign Prostatic Hyperplasia Treatment Market, by Type

    • 4.1 China Benign Prostatic Hyperplasia Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Benign Prostatic Hyperplasia Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Benign Prostatic Hyperplasia Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Benign Prostatic Hyperplasia Treatment Production Volume and Growth Rate of Laser Therapy

      • 4.5.2 China Benign Prostatic Hyperplasia Treatment Production Volume and Growth Rate of Drug Class

      • 4.5.3 China Benign Prostatic Hyperplasia Treatment Production Volume and Growth Rate of Minimally Invasive Surgeries

      • 4.5.4 China Benign Prostatic Hyperplasia Treatment Production Volume and Growth Rate of Others

    Chapter 5 China Benign Prostatic Hyperplasia Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Benign Prostatic Hyperplasia Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate of Ambulatory Surgical Centers

      • 5.5.2 China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate of Others

      • 5.5.3 China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate of Hospitals

      • 5.5.4 China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate of Specialty Clinics

    Chapter 6 China Benign Prostatic Hyperplasia Treatment Market, by Region

    • 6.1 China Benign Prostatic Hyperplasia Treatment Production Volume and Production Value, by Region

    • 6.2 China Benign Prostatic Hyperplasia Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Benign Prostatic Hyperplasia Treatment Market Analysis

    • 7.1 North China Benign Prostatic Hyperplasia Treatment Market, by Type

    • 7.2 North China Benign Prostatic Hyperplasia Treatment Market, by Application

    Chapter 8 Central China Benign Prostatic Hyperplasia Treatment Market Analysis

    • 8.1 Central China Benign Prostatic Hyperplasia Treatment Market, by Type

    • 8.2 Central China Benign Prostatic Hyperplasia Treatment Market, by Application

    Chapter 9 South China Benign Prostatic Hyperplasia Treatment Market Analysis

    • 9.1 South China Benign Prostatic Hyperplasia Treatment Market, by Type

    • 9.2 South China Benign Prostatic Hyperplasia Treatment Market, by Application

    Chapter 10 East China Benign Prostatic Hyperplasia Treatment Market Analysis

    • 10.1 East China Benign Prostatic Hyperplasia Treatment Market, by Type

    • 10.2 East China Benign Prostatic Hyperplasia Treatment Market, by Application

    Chapter 11 Northeast China Benign Prostatic Hyperplasia Treatment Market Analysis

    • 11.1 Northeast China Benign Prostatic Hyperplasia Treatment Market, by Type

    • 11.2 Northeast China Benign Prostatic Hyperplasia Treatment Market, by Application

    Chapter 12 Southwest China Benign Prostatic Hyperplasia Treatment Market Analysis

    • 12.1 Southwest China Benign Prostatic Hyperplasia Treatment Market, by Type

    • 12.2 Southwest China Benign Prostatic Hyperplasia Treatment Market, by Application

    Chapter 13 Northwest China Benign Prostatic Hyperplasia Treatment Market Analysis

    • 13.1 Northwest China Benign Prostatic Hyperplasia Treatment Market, by Type

    • 13.2 Northwest China Benign Prostatic Hyperplasia Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck

        • 14.1.1 Merck Company Profile

        • 14.1.2 Merck Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 LISA Laser

        • 14.2.1 LISA Laser Company Profile

        • 14.2.2 LISA Laser Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Olympus

        • 14.3.1 Olympus Company Profile

        • 14.3.2 Olympus Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Allergan plc

        • 14.4.1 Allergan plc Company Profile

        • 14.4.2 Allergan plc Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Astellas Pharma

        • 14.5.1 Astellas Pharma Company Profile

        • 14.5.2 Astellas Pharma Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Teleflex Incorporated

        • 14.6.1 Teleflex Incorporated Company Profile

        • 14.6.2 Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Boston Scientific Corporation

        • 14.7.1 Boston Scientific Corporation Company Profile

        • 14.7.2 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Endo International

        • 14.8.1 Endo International Company Profile

        • 14.8.2 Endo International Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Abbott

        • 14.9.1 Abbott Company Profile

        • 14.9.2 Abbott Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Pfizer

        • 14.10.1 Pfizer Company Profile

        • 14.10.2 Pfizer Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Sanofi

        • 14.11.1 Sanofi Company Profile

        • 14.11.2 Sanofi Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Boehringer Ingelheim GmbH

        • 14.12.1 Boehringer Ingelheim GmbH Company Profile

        • 14.12.2 Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 GlaxoSmithKline

        • 14.13.1 GlaxoSmithKline Company Profile

        • 14.13.2 GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Benign Prostatic Hyperplasia Treatment Industry Research Conclusions

    • 15.2 Benign Prostatic Hyperplasia Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Benign Prostatic Hyperplasia Treatment Industry Market Size (2018-2029)

    • Figure China Benign Prostatic Hyperplasia Treatment Production Volume, Production Value and Growth Rate of Laser Therapy (2018-2029)

    • Figure China Benign Prostatic Hyperplasia Treatment Production Volume, Production Value and Growth Rate of Drug Class (2018-2029)

    • Figure China Benign Prostatic Hyperplasia Treatment Production Volume, Production Value and Growth Rate of Minimally Invasive Surgeries (2018-2029)

    • Figure China Benign Prostatic Hyperplasia Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Benign Prostatic Hyperplasia Treatment Sales Volume, Sales Value and Growth Rate of Ambulatory Surgical Centers (2018-2029)

    • Figure China Benign Prostatic Hyperplasia Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Benign Prostatic Hyperplasia Treatment Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Benign Prostatic Hyperplasia Treatment Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)

    • Figure North China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate from 2018-2029

    • Figure Benign Prostatic Hyperplasia Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Benign Prostatic Hyperplasia Treatment Market Share by Type in 2018

    • Figure China Benign Prostatic Hyperplasia Treatment Market Share by Type in 2023

    • Figure China Benign Prostatic Hyperplasia Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Production Volume and Growth Rate of Laser Therapy (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Production Volume and Growth Rate of Drug Class (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Production Volume and Growth Rate of Minimally Invasive Surgeries (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Market Share by Application in 2018

    • Figure China Benign Prostatic Hyperplasia Treatment Market Share by Application in 2023

    • Figure China Benign Prostatic Hyperplasia Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate of Ambulatory Surgical Centers (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate of Others (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate of Specialty Clinics (2018-2023)

    • Table China Benign Prostatic Hyperplasia Treatment Production Volume by Region (2018-2023)

    • Table China Benign Prostatic Hyperplasia Treatment Production Volume Share by Region (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Production Volume Share by Region (2018-2023)

    • Table China Benign Prostatic Hyperplasia Treatment Production Value by Region (2018-2023)

    • Table China Benign Prostatic Hyperplasia Treatment Production Value Share by Region (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Production Value Share by Region (2018-2023)

    • Table China Benign Prostatic Hyperplasia Treatment Sales Volume by Region (2018-2023)

    • Table China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Region (2018-2023)

    • Table China Benign Prostatic Hyperplasia Treatment Sales Value by Region (2018-2023)

    • Table China Benign Prostatic Hyperplasia Treatment Sales Value Share by Region (2018-2023)

    • Figure China Benign Prostatic Hyperplasia Treatment Sales Value Share by Region (2018-2023)

    • Table North China Benign Prostatic Hyperplasia Treatment Production Volume by Type (2018-2023)

    • Table North China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Table North China Benign Prostatic Hyperplasia Treatment Sales Volume by Application (2018-2023)

    • Table North China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Benign Prostatic Hyperplasia Treatment Production Volume by Type (2018-2023)

    • Table Central China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Benign Prostatic Hyperplasia Treatment Sales Volume by Application (2018-2023)

    • Table Central China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Benign Prostatic Hyperplasia Treatment Production Volume by Type (2018-2023)

    • Table South China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Table South China Benign Prostatic Hyperplasia Treatment Sales Volume by Application (2018-2023)

    • Table South China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Benign Prostatic Hyperplasia Treatment Production Volume by Type (2018-2023)

    • Table East China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Table East China Benign Prostatic Hyperplasia Treatment Sales Volume by Application (2018-2023)

    • Table East China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Benign Prostatic Hyperplasia Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Benign Prostatic Hyperplasia Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Benign Prostatic Hyperplasia Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Benign Prostatic Hyperplasia Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Benign Prostatic Hyperplasia Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Benign Prostatic Hyperplasia Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Benign Prostatic Hyperplasia Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Benign Prostatic Hyperplasia Treatment Sales Volume Share by Application (2018-2023)

    • Table Merck Company Profile

    • Table Merck Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table LISA Laser Company Profile

    • Table LISA Laser Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table Olympus Company Profile

    • Table Olympus Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table Allergan plc Company Profile

    • Table Allergan plc Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table Teleflex Incorporated Company Profile

    • Table Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table Boston Scientific Corporation Company Profile

    • Table Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table Endo International Company Profile

    • Table Endo International Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table Abbott Company Profile

    • Table Abbott Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim GmbH Company Profile

    • Table Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US